Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Peak Bio (PKBOW) Competitors

PKBOW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying Peak Bio stock or one of its competitors? The main competitors of Peak Bio include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

Peak Bio vs.

Peak Bio (NASDAQ:PKBOW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Peak BioN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, Peak Bio's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Peak Bio Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
Peak BioN/A N/A N/A
180 Life Sciences N/A N/A N/A

Peak Bio and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Peak BioN/AN/A
180 Life SciencesN/AN/A

Summary

Peak Bio and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PKBOW vs. The Competition

MetricPeak BioBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$141.90M$5.14B$8.84B
Dividend YieldN/A3.50%5.05%4.07%
P/E RatioN/A326.96125.0517.04
Price / SalesN/A15,580.391,232.2287.12
Price / CashN/A12.1239.9936.27
Price / BookN/A7.336.956.36
Net IncomeN/A-$18.95M$119.41M$226.00M

Peak Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PKBOW
Peak Bio
N/A$0.00
flat
N/AN/A$0.00N/A0.00N/A
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A-25.0%$0.00N/A0.007Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.02
-50.0%
N/A-66.7%$0.00$418,304.000.002Gap Down
DRTSW
Alpha Tau Medical
N/A$0.16
-23.5%
N/A-15.4%$0.00N/A0.0080News Coverage
Gap Down
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.01
-1.0%
N/A-63.1%$0.00N/A0.0059Gap Down
BCTXW
BriaCell Therapeutics
N/A$0.31
-11.4%
N/A-80.6%$0.00N/A0.008Gap Down
High Trading Volume
CDIOW
Cardio Diagnostics
N/A$0.04
+32.2%
N/A-81.7%$0.00$35,688.000.007Gap Up
CTCXW
Carmell
N/A$0.09
-18.6%
N/AN/A$0.00$32,839.000.009Gap Down
CELUW
Celularity
N/A$0.02
flat
N/A+86.5%$0.00$42.69M0.00220Gap Down
CEROW
CERo Therapeutics
N/A$0.02
-3.3%
N/AN/A$0.00N/A0.008Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:PKBOW) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners